购物车
- 全部删除
- 您的购物车当前为空
MGD-28是一种强效的、具有口服活性的 Cullin-CRBN依赖性IKZF家族蛋白降解剂,能够剂量依赖性地以纳米摩尔的强度降解IKZF1(Ikaros)、IKZF2(Helios)和IKZF3(Aiolos)。MGD-28还能降解CK1α,在体外对多种血液癌细胞系显示出抗增殖活性,并在体内实验中具有抗肿瘤效果,常用于多发性骨髓瘤(MM)和血液病。
为众多的药物研发团队赋能,
让新药发现更简单!
MGD-28是一种强效的、具有口服活性的 Cullin-CRBN依赖性IKZF家族蛋白降解剂,能够剂量依赖性地以纳米摩尔的强度降解IKZF1(Ikaros)、IKZF2(Helios)和IKZF3(Aiolos)。MGD-28还能降解CK1α,在体外对多种血液癌细胞系显示出抗增殖活性,并在体内实验中具有抗肿瘤效果,常用于多发性骨髓瘤(MM)和血液病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 810 | 现货 | |
5 mg | ¥ 1,780 | 现货 | |
10 mg | ¥ 2,860 | 现货 | |
25 mg | ¥ 5,710 | 现货 | |
50 mg | ¥ 9,130 | 现货 | |
100 mg | ¥ 13,700 | 现货 |
产品描述 | MGD-28 is a potent, orally active Cullin-CRBN-dependent IKZF family protein degrader that dose-dependently degrades IKZF1 (Ikaros), IKZF2 (Helios), and IKZF3 (Aiolos) at nanomolar strengths.MGD-28 also degrades CK1α, and has shown antiproliferative activity against a variety of hematologic cancer cell lines showing antiproliferative activity in vitro and antitumor effects in in vivo assays, and is commonly used in multiple myeloma (MM) and hematological disorders. |
靶点活性 | IKZF3:7.1nM(DC50), CK1α:7.8nM(DC50), IZKF2:56.3nM(DC50), IKZF1:3.8nM(DC50) |
别名 | MGD28 |
分子量 | 595.67 |
分子式 | C33H34FN7O3 |
CAS No. | 2991818-13-2 |
Smiles | N#CC1=CC=C(C=C1F)N2CCN(CC3=CC=C(C=C3)CNC4=CC=CC=5C(=O)N(N(C)CC45)C6C(=O)NC(=O)CC6)CC2 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容